Legal Representation
Attorney
Victoria Friedman
USPTO Deadlines
Application History
9 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Dec 2, 2021 | ABN1 | O | ABANDONMENT - EXPRESS MAILED | Loading... |
Dec 2, 2021 | MAB1 | E | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | Loading... |
Dec 1, 2021 | EXAR | I | TEAS EXPRESS ABANDONMENT RECEIVED | Loading... |
Nov 21, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Nov 21, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Nov 21, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Nov 17, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jul 10, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Apr 6, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 040
Custom manufacture of pharmaceuticals, biopharmaceuticals, nutraceuticals, vitamins by pharmaceutical compounders
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Product development for others; Pharmaceutical drug development services; Scientific research and development; pharmaceutical research services; Research and development of new products; Consulting services in the field of pharmaceutical technology development; Biochemical research and analysis; Research services for biomedical science; Pharmaceutical preparations and medicines development; Pharmaceutical preparations and medicines development
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the word WuXiHybrid in Arial font.
Classification
International Classes
040
042